Glimser Forte 1 Tablet PR is a combination oral antidiabetic medication containing Glimepiride 1 mg and Metformin 1000 mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, stimulates pancreatic beta cells to enhance insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, resulting in reduced blood glucose levels. The combination of these two agents provides complementary mechanisms of action, making Glimser Forte 1 Tablet PR effective in achieving and maintaining target glycemic levels in patients inadequately controlled by diet, exercise, and monotherapy. This formulation is typically prescribed as part of a comprehensive diabetes management plan, including lifestyle modifications such as diet and physical activity. It is essential to monitor blood glucose levels regularly and assess renal function before and during treatment due to the risk of lactic acidosis associated with metformin. Common adverse effects may include gastrointestinal disturbances, hypoglycemia, and weight gain. Glimser Forte 1 Tablet PR should be used under medical supervision, with dosage adjustments based on therapeutic response and tolerability to optimize efficacy and minimize potential risks.